Wedemark, Germany

Stefan Stachelhaus

This inventor holds 4 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent. Top assignees: Kellbenx Inc., Adnagen Ag, Adnagen Gmbh. Active years: 2010-2016.

USPTO Granted Patents = 4 

% Patents Active = 75.0


Average Co-Inventor Count = 4.0

ph-index = 3

Forward Citations = 86(Granted Patents)


Company Filing History:


Years Active: 2010-2016

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Inventor Spotlight: Stefan Stachelhaus from Wedemark, Germany

Introduction

Stefan Stachelhaus, an accomplished inventor based in Wedemark, Germany, has made significant contributions to the field of biotechnology. With a total of four patents to his name, Stachelhaus has focused his research on developing innovative solutions that impact both medical and scientific communities.

Latest Patents

Among his latest innovations, Stefan Stachelhaus has developed a patent for "Monoclonal antibodies with specificity for fetal erythroid cells." This groundbreaking invention pertains to monoclonal antibodies and corresponding hybridoma cells suitable for isolating fetal cells from maternal blood. The uniqueness of this invention lies in the monoclonal antibody's ability to react specifically with a surface antigen present on fetal red blood cells, including their nucleated precursor cells, while not reacting with surface antigens found on adult erythroid cells.

Career Highlights

Throughout his career, Stefan Stachelhaus has been associated with notable companies such as Kellbenx Inc. and Adnagen AG. His work within these organizations has allowed him to advance his research and create impactful inventions that address critical issues in fetal medicine and diagnostics.

Collaborations

Collaboration has been key to his success, and Stefan has worked alongside esteemed colleagues such as Christiane Hollmann and Silke Zimmermann. These partnerships have facilitated the exchange of ideas and expertise, further enhancing the quality and reliability of his inventions.

Conclusion

Stefan Stachelhaus is a noteworthy inventor, whose work continues to pave the way for innovation in biotechnology. His patents, especially in the development of monoclonal antibodies for isolating fetal cells, illustrate the importance of inventive thinking in medical advancements. As he continues to explore new horizons in his field, the contributions of inventors like Stachelhaus remain essential for the progression of scientific research and healthcare solutions.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…